Pharmafile Logo

real-time data

KKR acquires clinical trials firm PRA International

Represents the second healthcare investment by the group in the last 12 months

Parexel adds flexibility to its clinical research offering

Also expands post marketing surveillances services in Japan

- PMLiVE

Baxter gets OK for BeneFix competitor in US

Rixubis becomes first new drug in its class in more than 15 years

- PMLiVE

GSK’s muscular dystrophy drug ‘a breakthrough’ says FDA

The antisense oligonucleotide is being developed by GlaxoSmithKline and Prosensa

- PMLiVE

US FDA nets $41m of illegal medicines in online pharmacy crackdown

Regulator shuts down 1,677 sites in global operation

- PMLiVE

EUSA founder joins Oxford BioTherapeutics as chairman

Bryan Morton has rich experience in oncology

- PMLiVE

Langland and McCann big winners at 2013 IPA Best of Health Awards

Langland and McCann Health China both receive ‘Best of Show’ honours at awards to recognise creativity in healthcare adveritsing

- PMLiVE

Ray Manna to head DJM in the US

DJM Digital Solutions has appointed Ray Manna as senior vice president, North America

- PMLiVE

Mike Birtwistle and Sarah Winstone to leave MHP Health Mandate

Rupert Gowrley and Rachel Rowson will take over as interim heads

- PMLiVE

Novartis and Savient face NICE rejections

Jakavi and Krystexxa turned down for NHS use in England and Wales

Novartis building

Novartis’ omalizumab on track for filing in serious skin disease

Is active ingredient in asthma drug Xolair

- PMLiVE

Merck Serono pushes into immunotherapies for cancer

Pharma company sets up dedicated R&D unit

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links